Nelson Castro

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 380 citations

Medicine, Pharmacology, Pharmacotherapy +12

Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study

Wojciech Jurczak, Ilídia Moreira, Govind Babu Kanakasetty et al. · The Lancet Haematology · 2017 · 82 citations · Full text

Medicine, Oncology, Pharmacotherapy +6

Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock

Fernando Pálizas, Bernardo Lattanzio, Natalia Durandal et al. · JAMA · 2025 · 63 citations · Full text

Medicine, Perioperative Medicine, Hemodynamic Management +16

Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry

Irène Biasoli, Nelson Castro, Márcia Torresan Delamain et al. · International Journal of Cancer · 2017 · 33 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry

Irène Biasoli, Nelson Castro, Marcia Delamain et al. · Hematological Oncology · 2017 · 23 citations · Full text

Medicine, Oncology, Clinical Epidemiology +14